Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Vista Pharmaceuticals Ltd
Your Vote -
Buy
75.00%
Hold
0.00%
Sell
25.00%
75.00%
4 users have voted
Option Chain
Analyzes market sentiment, predicts Vista Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Vista Pharmaceut posts Q4 net loss of Rs 1.50 cr
-
Vista Pharmaceut - Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure
-
Vista Pharmaceut - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.20
-
Vista Pharmaceut - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
-
Vista Pharmaceut - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Vista Pharmaceut - General Announcement - Financials Results
-
Vista Pharmaceut - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Vista Pharmaceut has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Vista Pharmaceut - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Vista Pharmaceut - Shareholder Meeting / Postal Ballot-Outcome of EGM
Key fundamentals
Evaluate the intrinsic value of Vista Pharmaceuticals Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 52.827 | 48.4271 | 46.6666 | 48.004 | 47.8226 |
| Liabilities | 52.827 | 48.4271 | 46.6666 | 48.004 | 47.8226 |
| Equity | 12.3104 | 9.433 | 7.5113 | 7.3588 | 7.3588 |
| Gross Profit | -4.0283 | -3.5713 | -4.4446 | -1.2106 | -1.7297 |
| Net Profit | -4.6487 | -4.512 | -5.662 | -0.8319 | -1.8852 |
| Cash From Operating Activities | -6.9845 | -4.914 | -1.7114 | -0.993 | -6.7466 |
| NPM(%) | -46.14 | -43.85 | -564.11 | -210.82 | -148.86 |
| Revenue | 10.0746 | 10.2878 | 1.0037 | 0.3946 | 1.2664 |
| Expenses | 14.1029 | 13.8591 | 5.4483 | 1.6052 | 2.9961 |
| ROE(%) | -10.72 | -10.41 | -13.06 | -1.91 | -4.34 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Vista Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 859.90 | 1.12 | 28.38 | 6.62 | 301.39 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 72.27 | -2.54 | 205.89 | 24.12 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 26.00 | 1.13 | 0.00 | 50.09 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 806.15 | -0.38 | 0.00 | 22.75 | -687.10 | 0.00 |
Company Info
Vista Pharmaceuticals Limited was incorporated on 25.01.1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh and has obtained Certificate of Commencement of Business on 7th February 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli and his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of the State of New Jersy, United States of America. The company is setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets and 200 million capsules per annum. 2003 -To issue 352907 fully convertible warrants on preferential basis to Vista Pharmaceuticals Inc convertible into one equity share within a period of 18 months at a conversion price of Rs 10/- -Increase the Authorised capital from Rs 80 million to Rs 100 million.
Vista Pharmaceuticals Limited was incorporated on 25.01.1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh and has obtained Certificate of Commencement of Business on 7th February 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli and his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of the State of New Jersy, United States of America. The company is setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets and 200 million capsules per annum. 2003 -To issue 352907 fully convertible warrants on preferential basis to Vista Pharmaceuticals Inc convertible into one equity share within a period of 18 months at a conversion price of Rs 10/- -Increase the Authorised capital from Rs 80 million to Rs 100 million.
Read More
Parent Organisation
Vista Pharmaceuticals Ltd.
Founded
25/01/1991
Managing Director
Mr.Murali Meraga
NSE Symbol
FAQ
The current price of Vista Pharmaceuticals Ltd is
The 52-week high for Vista Pharmaceuticals Ltd is
The market capitalization of Vista Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Vista Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Vista Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vista Pharmaceuticals Ltd shares.
The CEO of Vista Pharmaceuticals Ltd is Mr.Murali Meraga, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
